Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children

Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children

Submitted by admin on April 27, 2023 - 10:56pm
Source: 
Seeking Alpha
News Tags: 
Pfizer
vaccines
FDA
Prevnar 20
pneumococcal disease
pediatric
Headline: 
Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children
snippet: 

Pfizer (NYSE:PFE) announced Thursday that the FDA approved its pneumonia vaccine Prevnar 20 for use in infants and children six weeks through 17 years of age for the prevention of invasive pneumococcal disease (IPD).

Do Not Allow Advertisers to Use My Personal information